A carregar...

Systematic review of pharmacogenetic testing for predicting clinical benefit to anti-EGFR therapy in metastatic colorectal cancer

Pharmacogenetic testing can help identify patients with metastatic colorectal cancer more likely to respond to anti-EGFR therapy. We systematically reviewed the benefits and harms of EGFR-related pharmacogenetic testing of molecular targets downstream to KRAS in the treatment of metastatic colorecta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lin, Jennifers, Webber, Elizabeth M, Senger, Caitlyn A, Holmes, Rebecca S, Whitlock, Evelyn P
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139487/
https://ncbi.nlm.nih.gov/pubmed/21779535
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!